Imani S - Search Results

1

Hematopoietic-Specific Deletion of Foxo1 Promotes NK Cell Specification and Proliferation.

Huang P, Wang F, Yang Y, Lai W, Meng M, Wu S, Peng H, Wang L, Zhan R, Imani S, Yu J, Chen B, Li X, Deng Y. Huang P, et al. Among authors: imani s. Front Immunol. 2019 May 8;10:1016. doi: 10.3389/fimmu.2019.01016. eCollection 2019. Front Immunol. 2019. PMID: 31139183 Free PMC article.

2

Novel pathogenic CERKL variant in Iranian familial with inherited retinal dystrophies: genotype-phenotype correlation.

Fu S, Fu J, Mobasher-Jannat A, Jadidi K, Li Y, Chen R, Imani S, Cheng J. Fu S, et al. Among authors: imani s. 3 Biotech. 2023 Jun;13(6):166. doi: 10.1007/s13205-023-03535-w. Epub 2023 May 6. 3 Biotech. 2023. PMID: 37162806

3

NCF2, MYO1F, S1PR4, and FCN1 as potential noninvasive diagnostic biomarkers in patients with obstructive coronary artery: A weighted gene co-expression network analysis.

Mo XG, Liu W, Yang Y, Imani S, Lu S, Dan G, Nie X, Yan J, Zhan R, Li X, Deng Y, Chen B, Cai Y. Mo XG, et al. Among authors: imani s. J Cell Biochem. 2019 Oct;120(10):18219-18235. doi: 10.1002/jcb.29128. Epub 2019 Jun 27. J Cell Biochem. 2019. PMID: 31245869 Free PMC article.

4

Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies.

Naqvi SSZH, Imani S, Hosseinifard H, Wen QL, Shahzad MN, Ijaz I, Deng Y, Guo M, Xu Y. Naqvi SSZH, et al. Among authors: imani s. BMC Endocr Disord. 2019 Nov 25;19(1):125. doi: 10.1186/s12902-019-0453-5. BMC Endocr Disord. 2019. PMID: 31767009 Free PMC article.

5

Unique Phenotypes of Heart Resident Type 2 Innate Lymphoid Cells.

Deng Y, Wu S, Yang Y, Meng M, Chen X, Chen S, Li L, Gao Y, Cai Y, Imani S, Chen B, Li S, Deng Y, Li X. Deng Y, et al. Among authors: imani s. Front Immunol. 2020 May 5;11:802. doi: 10.3389/fimmu.2020.00802. eCollection 2020. Front Immunol. 2020. PMID: 32431711 Free PMC article.

6

Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance.

Liu S, Imani S, Deng Y, Pathak JL, Wen Q, Chen Y, Wu J. Liu S, et al. Among authors: imani s. Onco Targets Ther. 2020 Jun 24;13:6037-6050. doi: 10.2147/OTT.S256708. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606809 Free PMC article. Review.

7

Landscape of active enhancers developed de novo in cirrhosis and conserved in hepatocellular carcinoma.

Yang Y, Deng X, Chen X, Chen S, Song L, Meng M, Han Q, Imani S, Li S, Zhong Z, Li X, Deng Y. Yang Y, et al. Among authors: imani s. Am J Cancer Res. 2020 Oct 1;10(10):3157-3178. eCollection 2020. Am J Cancer Res. 2020. PMID: 33163263 Free PMC article.

8

Natural Killer Cells: Friend or Foe in Metabolic Diseases?

Li Y, Wang F, Imani S, Tao L, Deng Y, Cai Y. Li Y, et al. Among authors: imani s. Front Immunol. 2021 Feb 24;12:614429. doi: 10.3389/fimmu.2021.614429. eCollection 2021. Front Immunol. 2021. PMID: 33717101 Free PMC article. Review.

9

PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer.

Yang G, Liu S, Maghsoudloo M, Shasaltaneh MD, Kaboli PJ, Zhang C, Deng Y, Heidari H, Entezari M, Fu S, Wen Q, Imani S. Yang G, et al. Among authors: imani s. Sci Rep. 2021 Mar 15;11(1):6056. doi: 10.1038/s41598-021-85595-7. Sci Rep. 2021. PMID: 33723350 Free PMC article. Clinical Trial.

10

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.

Guo R, Liu T, Shasaltaneh MD, Wang X, Imani S, Wen Q. Guo R, et al. Among authors: imani s. Front Oncol. 2022 Jun 27;12:829212. doi: 10.3389/fonc.2022.829212. eCollection 2022. Front Oncol. 2022. PMID: 35832555 Free PMC article. Review.

11

Anlotinib Suppresses Colorectal Cancer Proliferation and Angiogenesis via Inhibition of AKT/ERK Signaling Cascade.

Yang Q, Ni L, Imani S, Xiang Z, Hai R, Ding R, Fu S, Wu JB, Wen Q. Yang Q, et al. Among authors: imani s. Cancer Manag Res. 2020 Jun 24;12:4937-4948. doi: 10.2147/CMAR.S252181. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606981 Free PMC article.

12

Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis.

Imani S, Hosseinifard H, Cheng J, Wei C, Fu J. Imani S, et al. Sci Rep. 2016 Jun 23;6:28587. doi: 10.1038/srep28587. Sci Rep. 2016. PMID: 27335258 Free PMC article.

13

Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.

Cheng J, Fu S, Wei C, Tania M, Khan MA, Imani S, Zhou B, Chen H, Xiao X, Wu J, Fu J. Cheng J, et al. Among authors: imani s. Cancer Biomark. 2017;19(1):85-92. doi: 10.3233/CBM-160380. Cancer Biomark. 2017. PMID: 28269754

14

The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.

Imani S, Zhang X, Hosseinifard H, Fu S, Fu J. Imani S, et al. Oncotarget. 2017 Apr 4;8(14):23177-23187. doi: 10.18632/oncotarget.15520. Oncotarget. 2017. PMID: 28423566 Free PMC article. Review.

15

Identification of a novel RPGRIP1 mutation in an Iranian family with leber congenital amaurosis by exome sequencing.

Imani S, Cheng J, Mobasher-Jannat A, Wei C, Fu S, Yang L, Jadidi K, Khosravi MH, Mohazzab-Torabi S, Shasaltaneh MD, Li Y, Chen R, Fu J. Imani S, et al. J Cell Mol Med. 2018 Mar;22(3):1733-1742. doi: 10.1111/jcmm.13454. Epub 2017 Nov 29. J Cell Mol Med. 2018. PMID: 29193763 Free PMC article.

16

Genetic identification and molecular modeling characterization reveal a novel PROM1 mutation in Stargardt4-like macular dystrophy.

Imani S, Cheng J, Shasaltaneh MD, Wei C, Yang L, Fu S, Zou H, Khan MA, Zhang X, Chen H, Zhang D, Duan C, Lv H, Li Y, Chen R, Fu J. Imani S, et al. Oncotarget. 2017 Nov 9;9(1):122-141. doi: 10.18632/oncotarget.22343. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416601 Free PMC article.

17

Molecular genetics ‎characterization and homology modeling of the CHM gene mutation: A study on its association with choroideremia.

Imani S, Ijaz I, Shasaltaneh MD, Fu S, Cheng J, Fu J. Imani S, et al. Mutat Res Rev Mutat Res. 2018 Jan-Mar;775:39-50. doi: 10.1016/j.mrrev.2018.02.001. Epub 2018 Feb 18. Mutat Res Rev Mutat Res. 2018. PMID: 29555028 Review.

18

In silico data analyses of the hotspot mutations of CHM gene in choroideremia disease.

Imani S, Ijaz I, Shasaltaneh MD, Fu S, Cheng J, Fu J. Imani S, et al. Data Brief. 2018 Apr 12;18:1217-1223. doi: 10.1016/j.dib.2018.04.023. eCollection 2018 Jun. Data Brief. 2018. PMID: 29900297 Free PMC article.

19

Novel splicing variant c. 208+2T>C in BBS5 segregates with Bardet-Biedl syndrome in an Iranian family by targeted exome sequencing.

Imani S, Cheng J, Fu J, Mobasher-Jannat A, Wei C, Mohazzab-Torabi S, Jadidi K, Khosravi MH, Shasaltaneh MD, Yang L, Khan MA, Fu J. Imani S, et al. Biosci Rep. 2019 Mar 28;39(3):BSR20181544. doi: 10.1042/BSR20181544. Print 2019 Mar 29. Biosci Rep. 2019. PMID: 30850397 Free PMC article.

20

Epigenetic identification of ADCY4 as a biomarker for breast cancer: an integrated analysis of adenylate cyclases.

Fan Y, Mu J, Huang M, Imani S, Wang Y, Lin S, Fan J, Wen Q. Fan Y, et al. Among authors: imani s. Epigenomics. 2019 Nov;11(14):1561-1579. doi: 10.2217/epi-2019-0207. Epub 2019 Oct 4. Epigenomics. 2019. PMID: 31584294 Free article.

21

The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis.

Zhang Z, Imani S, Shasaltaneh MD, Hosseinifard H, Zou L, Fan Y, Wen Q. Zhang Z, et al. Among authors: imani s. BMC Cancer. 2019 Nov 21;19(1):1134. doi: 10.1186/s12885-019-6350-5. BMC Cancer. 2019. PMID: 31752759 Free PMC article.

22

Comparison of different images in gross target volume delineating on VX2 nasopharyngeal transplantation tumor models.

Xiang ZQ, Imani S, Hu Y, Ding RL, Pang HW, Chen Y, Fu SZ, Xie F, He WF, Wen QL. Xiang ZQ, et al. Among authors: imani s. J Cancer. 2020 Jan 1;11(5):1104-1114. doi: 10.7150/jca.36076. eCollection 2020. J Cancer. 2020. PMID: 31956357 Free PMC article.

23

Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo.

Wang M, Zeng Q, Li Y, Imani S, Xie D, Li Y, Han Y, Fan J. Wang M, et al. Among authors: imani s. J Drug Target. 2020 Nov;28(9):961-969. doi: 10.1080/1061186X.2020.1764963. Epub 2020 May 18. J Drug Target. 2020. PMID: 32374627

24

Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.

Zou L, Imani S, Maghsoudloo M, Shasaltaneh MD, Gao L, Zhou J, Wen Q, Liu S, Zhang L, Chen G. Zou L, et al. Among authors: imani s. Oncol Rep. 2020 Sep;44(3):1075-1093. doi: 10.3892/or.2020.7650. Epub 2020 Jun 18. Oncol Rep. 2020. PMID: 32705227 Free PMC article.

25

Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.

Han X, Liu S, Yang G, Hosseinifard H, Imani S, Yang L, Maghsoudloo M, Fu S, Wen Q, Liu Q. Han X, et al. Among authors: imani s. Gynecol Oncol. 2021 Jan;160(1):351-360. doi: 10.1016/j.ygyno.2020.10.011. Epub 2020 Oct 19. Gynecol Oncol. 2021. PMID: 33092868

26

Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer.

Yang J, Wu Z, Chen Y, Hu C, Li D, Chen Y, Imani S, Wen Q, Fu S, Wu J. Yang J, et al. Among authors: imani s. J Cancer Res Clin Oncol. 2021 Feb;147(2):411-422. doi: 10.1007/s00432-020-03434-0. Epub 2020 Nov 1. J Cancer Res Clin Oncol. 2021. PMID: 33130941

27

Descriptive statistics of dataset from the meta-analysis and meta-regression analysis on prognostic significance of pre-treatment systemic hemato-immunological indices of cervical cancer patients.

Han X, Liu S, Hosseinifard H, Imani S, Yang G, Yang L, Maghsoudloo M, Fu S, Wen Q, Liu Q. Han X, et al. Among authors: imani s. Data Brief. 2021 Mar 3;35:106925. doi: 10.1016/j.dib.2021.106925. eCollection 2021 Apr. Data Brief. 2021. PMID: 33850979 Free PMC article.

28

Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.

Fan Y, Wang Y, He L, Imani S, Wen Q. Fan Y, et al. Among authors: imani s. ESMO Open. 2021 Aug;6(4):100232. doi: 10.1016/j.esmoop.2021.100232. Epub 2021 Aug 13. ESMO Open. 2021. PMID: 34392135 Free PMC article.

29

Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy.

Kaboli PJ, Imani S, Jomhori M, Ling KH. Kaboli PJ, et al. Among authors: imani s. Am J Cancer Res. 2021 Oct 15;11(10):5155-5183. eCollection 2021. Am J Cancer Res. 2021. PMID: 34765318 Free PMC article. Review.

30

PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway.

Zhou J, Imani S, Shasaltaneh MD, Liu S, Lu T, Fu J. Zhou J, et al. Among authors: imani s. Mol Biol Rep. 2022 Mar;49(3):1799-1816. doi: 10.1007/s11033-021-06990-x. Epub 2021 Nov 23. Mol Biol Rep. 2022. PMID: 34816327

31

Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy.

Xiang Z, Deng X, He W, Yang Q, Ni L, Dehghan Shasaltaneh M, Maghsoudloo M, Yang G, Wu J, Imani S, Wen Q. Xiang Z, et al. Among authors: imani s. Ann Med. 2022 Dec;54(1):1357-1371. doi: 10.1080/07853890.2022.2071977. Ann Med. 2022. PMID: 35543207 Free PMC article.

32

Histochemical Staining of Vasculogenic Mimicry.

Imani S, Liu S, Maghsoudloo M, Wen Q. Imani S, et al. Methods Mol Biol. 2022;2514:107-120. doi: 10.1007/978-1-0716-2403-6_11. Methods Mol Biol. 2022. PMID: 35771423 Review.

33

Comparative mRNA/micro-RNA co-expression network drives melanomagenesis by promoting epithelial-mesenchymal transition and vasculogenic mimicry signaling.

He W, Yang G, Liu S, Maghsoudloo M, Shasaltaneh MD, Kaboli PJ, Zhang C, Zhang J, Entezari M, Imani S, Wen Q. He W, et al. Among authors: imani s. Transl Oncol. 2021 Dec;14(12):101237. doi: 10.1016/j.tranon.2021.101237. Epub 2021 Oct 6. Transl Oncol. 2021. PMID: 34626953 Free PMC article.

34

Diagnostic Role of Extracellular Vesicles in Cancer: A Comprehensive Systematic Review and Meta-Analysis.

Liu SY, Liao Y, Hosseinifard H, Imani S, Wen QL. Liu SY, et al. Among authors: imani s. Front Cell Dev Biol. 2021 Oct 15;9:705791. doi: 10.3389/fcell.2021.705791. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34722499 Free PMC article.

35

Editorial: Molecular Targeted Therapy in Oncology: Lessons From Pharmacogenetics and Pharmacoepigenetics.

Imani S, Becatti M, Khan MA. Imani S, et al. Front Mol Biosci. 2022 Mar 15;9:822188. doi: 10.3389/fmolb.2022.822188. eCollection 2022. Front Mol Biosci. 2022. PMID: 35372509 Free PMC article. No abstract available.

36

MicroRNA-34 family in breast cancer: from research to therapeutic potential.

Imani S, Wu RC, Fu J. Imani S, et al. J Cancer. 2018 Sep 28;9(20):3765-3775. doi: 10.7150/jca.25576. eCollection 2018. J Cancer. 2018. PMID: 30405848 Free PMC article. Review.

37

Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.

Jabbarzadeh Kaboli P, Luo S, Chen Y, Jomhori M, Imani S, Xiang S, Wu Z, Li M, Shen J, Zhao Y, Wu X, Hin Cho C, Xiao Z. Jabbarzadeh Kaboli P, et al. Among authors: imani s. Gene. 2022 Mar 30;816:146171. doi: 10.1016/j.gene.2021.146171. Epub 2022 Jan 10. Gene. 2022. PMID: 35026293

38

Correlation between HFE gene polymorphisms and increased risk of coronary artery disease among patients with type 2 diabetes in Iran.

Saremi L, Saremi M, Lotfipanah S, İmani S, Fu J, Zhang T. Saremi L, et al. Among authors: imani s. Turk J Med Sci. 2016 Apr 19;46(3):590-6. doi: 10.3906/sag-1409-88. Turk J Med Sci. 2016. PMID: 27513231 Free article.

39

Epigenetic: A missing paradigm in cellular and molecular pathways of sulfur mustard lung: a prospective and comparative study.

Imani S, Panahi Y, Salimian J, Fu J, Ghanei M. Imani S, et al. Iran J Basic Med Sci. 2015 Aug;18(8):723-36. Iran J Basic Med Sci. 2015. PMID: 26557960 Free PMC article. Review.

40

Genetic Authentication of Gardenia jasminoides Ellis var. grandiflora Nakai by Improved RAPD-Derived DNA Markers.

Mei Z, Zhou B, Wei C, Cheng J, Imani S, Chen H, Fu J. Mei Z, et al. Among authors: imani s. Molecules. 2015 Nov 10;20(11):20219-29. doi: 10.3390/molecules201119687. Molecules. 2015. PMID: 26569205 Free PMC article.

41

Development of SCAR Markers Based on Improved RAPD Amplification Fragments and Molecular Cloning for Authentication of Herbal Medicines Angelica sinensis, Angelica acutiloba and Levisticum officinale.

Zhang C, Mei Z, Cheng J, He Y, Khan MA, Luo P, Imani S, Fu J. Zhang C, et al. Among authors: imani s. Nat Prod Commun. 2015 Oct;10(10):1743-7. Nat Prod Commun. 2015. PMID: 26669116

42

Imani S, Salimian J, Fu J, Ghanei M, Panahi Y. Imani S, et al. Immunopharmacol Immunotoxicol. 2016 Aug;38(4):270-80. doi: 10.1080/08923973.2016.1188402. Epub 2016 May 31. Immunopharmacol Immunotoxicol. 2016. PMID: 27241137 Clinical Trial.

43

An improved DNA marker technique for genetic characterization using RAMP-PCR with high-GC primers.

Wei CL, Cheng JL, Khan MA, Yang LQ, Imani S, Chen HC, Fu JJ. Wei CL, et al. Among authors: imani s. Genet Mol Res. 2016 Sep 16;15(3). doi: 10.4238/gmr.15038721. Genet Mol Res. 2016. PMID: 27706740 Free article.

44

MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.

Imani S, Wei C, Cheng J, Khan MA, Fu S, Yang L, Tania M, Zhang X, Xiao X, Zhang X, Fu J. Imani S, et al. Oncotarget. 2017 Mar 28;8(13):21362-21379. doi: 10.18632/oncotarget.15214. Oncotarget. 2017. PMID: 28423483 Free PMC article.

45

Genetic analysis of Canarium album in different areas of China by improved RAPD and ISSR.

Mei Z, Zhang X, Liu X, Imani S, Fu J. Mei Z, et al. Among authors: imani s. C R Biol. 2017 Nov-Dec;340(11-12):558-564. doi: 10.1016/j.crvi.2017.09.006. Epub 2017 Nov 1. C R Biol. 2017. PMID: 29100782 Free article.

46

Parental age-related risk of retinoblastoma in Iranian children.

Saremi L, Imani S, Rostaminia M, Nadeali Z. Saremi L, et al. Among authors: imani s. Asian Pac J Cancer Prev. 2014;15(6):2847-50. doi: 10.7314/apjcp.2014.15.6.2847. Asian Pac J Cancer Prev. 2014. PMID: 24761912 Free article. Clinical Trial.

47

A novel homozygous variant of GPR98 causes usher syndrome type IIC in a consanguineous Chinese family by next generation sequencing.

Wei C, Yang L, Cheng J, Imani S, Fu S, Lv H, Li Y, Chen R, Leung EL, Fu J. Wei C, et al. Among authors: imani s. BMC Med Genet. 2018 Jun 11;19(1):99. doi: 10.1186/s12881-018-0602-0. BMC Med Genet. 2018. PMID: 29890953 Free PMC article.

48

Statistical approach to discovery of factors impacting on emergence of blood cancers in iran.

Zand AM, Imani S, Saadati M, Ziaei R, Borna H, Zaefizadeh M, Shazad B. Zand AM, et al. Among authors: imani s. Asian Pac J Cancer Prev. 2012;13(12):5965-7. doi: 10.7314/apjcp.2012.13.12.5965. Asian Pac J Cancer Prev. 2012. PMID: 23464386 Free article.

49

Therapeutic face of RNAi: in vivo challenges.

Borna H, Imani S, Iman M, Azimzadeh Jamalkandi S. Borna H, et al. Among authors: imani s. Expert Opin Biol Ther. 2015 Feb;15(2):269-85. doi: 10.1517/14712598.2015.983070. Epub 2014 Nov 15. Expert Opin Biol Ther. 2015. PMID: 25399911 Review.

50

Assessment of Treg/Th17 axis role in immunopathogenesis of chronic injuries of mustard lung disease.

Imani S, Salimian J, Bozorgmehr M, Vahedi E, Ghazvini A, Ghanei M, Panahi Y. Imani S, et al. J Recept Signal Transduct Res. 2016 Oct;36(5):531-41. doi: 10.3109/10799893.2016.1141953. Epub 2016 Feb 19. J Recept Signal Transduct Res. 2016. PMID: 26895417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page